ACUTE MYELOID LEUKEMIA 

damlaaaaScientific Chair: Gert Ossenkoppele (VU University Medical Center Amsterdam, The Netherlands)

*AML Treatment Beyond 3+7: Hartmut Dohner (University Hospital,Ulm, DE)
*The Emerging Role of MRD in AML: Gert Ossenkoppele (VU University Medical Center Amsterdam, The Netherlands)
*Immunetherapy in AML: Form AlloSCT Towards CARt Cell Therapy: Marion Subklewe (Ludwig Maximilian University, Deutschland)

MULTIPLE MYELOMA 

damlaaaaScientific Chair: Pieter Sonneveld (Erasmus MC, The Netherlands)

HODGKIN LYMPHOMA 

damlaaaaScientific Chair: Andreas Engert (University Hospital of Cologne, Germany)

ACUTE LYMPHOBLASTIC LEUKEMIA 

damlaaaaScientific Chair: Dieter Hoelzer (University of Frankfurt, Germany)

INDOLENT LYMPHOMAS 

damlaaaaScientific Chair: Eva Kimby (Karolinska Institute, Sweeden)

CHRONIC MYELOID LEUKEMIA 

damlaaaaScientific Chair: Jane Apperley (Imperial College London, UK)

CHRONIC LYMPHOCYTIC LEUKEMIA 

damlaaaaScientific Chair: John Gribben (Barts Cancer Institute Center for Haemato-Oncology, UK)

AGGRESSIVE LYMPHOMAS 

damlaaaaScientific Chair: Martin Dreyling (Klinikum der Universität LMU München, Germany)